Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (168)

2024

  1. Differences in the clinical and hormonal presentation of patients with familial and sporadic primary aldosteronism

    Frontiers in Endocrinology, Vol. 15

  2. Is adrenal venous sampling always necessary to differentiate between unilateral and bilateral primary aldosteronism? Lesson from the SPAIN-ALDO register

    Endocrine, Vol. 84, Núm. 2, pp. 683-693

  3. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

  4. Renin as a Biomarker to Guide Medical Treatment in Primary Aldosteronism Patients. Findings from the SPAIN-ALDO Registry

    High Blood Pressure and Cardiovascular Prevention, Vol. 31, Núm. 1, pp. 43-53

  5. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

  6. Surgery for inflammatory bowel disease in Spain: How are we doing? Initial results of a nationwide prospective registry

    Cirugia Espanola

  7. Textbook outcomes in the liver-first approach for colorectal liver metastases: prospective multicentre analysis

    BJS Open, Vol. 8, Núm. 1

  8. The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis

    Journal of Gastroenterology

  9. Utility of non-invasive monitoring of exhaled carbon dioxide and perfusion index in adult patients in the emergency department

    American Journal of Emergency Medicine, Vol. 79, pp. 85-90

2023

  1. Autonomous cortisol secretion in patients with primary aldosteronism: prevalence and implications on cardiometabolic profile and on surgical outcomes

    Endocrine Connections, Vol. 12, Núm. 9

  2. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  3. Decreased muscle mass in type-2 diabetes. A hidden comorbidity to consider

    Nutricion Hospitalaria, Vol. 40, Núm. 1, pp. 59-66

  4. Effect of Obesity on Clinical Characteristics of Primary Aldosteronism Patients at Diagnosis and Postsurgical Response

    The Journal of clinical endocrinology and metabolism, Vol. 109, Núm. 1, pp. e379-e388

  5. Expert Consensus on Morphofunctional Assessment in Disease-Related Malnutrition. Grade Review and Delphi Study

    Nutrients, Vol. 15, Núm. 3

  6. Expert Recommendations for Using Time-in-Range and Other Continuous Glucose Monitoring Metrics to Achieve Patient-Centered Glycemic Control in People With Diabetes

    Journal of Diabetes Science and Technology, Vol. 17, Núm. 5, pp. 1326-1336

  7. Iberian experience with PASCAL transcatheter edge-to-edge repair for mitral valve regurgitation

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 25-31

  8. Nutritional ultrasound®: Conceptualisation, technical considerations and standardisation

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 74-84

  9. Prevalence, risk factors and evolution of diabetes mellitus after treatment in primary aldosteronism. Results from the SPAIN-ALDO registry

    Journal of Endocrinological Investigation, Vol. 46, Núm. 11, pp. 2343-2352

  10. Protocol for a prospective cohort study on the feasibility of application of nutritional ultrasound in the diagnosis and follow-up of patients with nutritional risk at hospital discharge: study on body composition and function (DRECO)

    BMJ Open, Vol. 13, Núm. 12

  11. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031